Table 4.
Group | n | Treatmentb | Survival times (days) | Mean survival ±SD (days) |
P valuec | GVHD |
---|---|---|---|---|---|---|
IC | 14 | — | 25, 24, 21, 17, 17, 16, 12, 11, 11, 10, 9, 8, 7, 7 |
13.9±6.1 | — | 6/14 d |
IIC | 8 | FK long course | >214, >214, >213, >213, >212, >206, >202, 7 |
188.0±72.1 | 0.0002 | 1/8e,f |
VIII | 6 | CsA 20 inter- mediate course |
>104, 53, 50, 8, 7, 7 | 38.3±38.6 | 0.1035 | 2/6 |
Genetically restricted to GVHD; graft rejection is not possible in this model.
Refer to Table 1.
Generalized savage (Mantel-Cox) value comparing survival times to that of untreated controls.
Four other animals demonstrated findings suggestive of GVHD.
Chi-square, P value <0.05.
Lone animal that developed GVHD is alive with resolution of the disease.